| ［1］ |
Lan Y，Wu D，Cai Z，et al.Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults：a prospective cohort study ［J］.Cardiovascular diabetology，2023，22（1）：181.
|
| ［2］ |
胡仁明，谢颖，鹿斌，等.2型糖尿病患者高发“代谢性炎症综合征”［J］.中华内分泌代谢杂志，2016，32（01）：27-32.
|
| ［3］ |
Pories WJ，MacDonald KG，Jr.Morgan EJ，et al.Surgical treatment of obesity and its effect on diabetes：10-y follow-up ［J］.The American journal of clinical nutrition，1992，55（2 Suppl）：582s-585s.
|
| ［4］ |
Le Chatelier E，Nielsen T，Qin J，et al.Richness of human gut microbiome correlates with metabolic markers ［J］.Nature，2013，500（7464）：541-546.
|
| ［5］ |
Han Y，Kim G，Ahn E，et al.Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota on host metabolism after bariatric surgery ［J］.Diabetes，obesity & metabolism，2022，24（7）：1224-1234.
|
| ［6］ |
Moreira S，Bachi ALL，Jirjos EI，et al.Roux-en-Y Gastric Bypass Improves Adiponectin to Leptin Ratio and Inflammatory Profile in Severely Obese Women with and without Metabolic Syndrome：A Randomized Controlled Trial ［J］.Nutrients，2023，15（15）：3312.
|
| ［7］ |
Mingrone G，Bornstein SR.Gain in survival after metabolic-bariatric surgery ［J］.Lancet （London，England），2021，397（10287）：1785-1787.
|
| ［8］ |
Harris E.Weight loss surgery managed blood pressure for people with obesity ［J］.JAMA，2024，331（9）：725-726.
|
| ［9］ |
Robert M，Poghosyan T，Maucort-Boulch D，et al.Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years （YOMEGA）：a prospective，open-label，non-inferiority，randomised extension study ［J］.The lancet Diabetes & endocrinology，2024，12（4）：267-276.
|
| ［10］ |
Shapiro WL，Kunani P，Sidell M A，et al.Prevalence of adolescents meeting criteria for metabolic and bariatric surgery ［J］.Pediatrics，2024，153（3）：e2023063916.
|
| ［11］ |
Shah A，Liang NE，Bruzoni M，et al.Outcomes after metabolic and bariatric surgery in preteens versus teens using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database and center-specific data ［J］.Obesity （Silver Spring，Md），2024，32（1）：150-155.
|
| ［12］ |
Dowgiałło-Gornowicz N，Lech P，Major P.Bariatric and metabolic surgery in patients older than 65 years - a multicenter study ［J］.Obesity surgery，2023，33（10）：3106-3111.
|
| ［13］ |
Xiang Q，Yu M，Cai Q，et al.Multi-omics insights into the microbiotagut-brain axis and cognitive improvement post-bariatric surgery ［J］.Journal of translational medicine，2024，22（1）：945.
|
| ［14］ |
Smith KR，Steele KE，Papantoni A，et al.The relationship between weight loss and cognitive function in bariatric surgery ［J］.Surgical endoscopy，2023，37（3）：1976-1984.
|
| ［15］ |
Zhang S，Dang Y.Roles of gut microbiota and metabolites in overweight and obesity of children ［J］.Frontiers in endocrinology，2022，13：994930.
|
| ［16］ |
Vaiserman A，Romanenko M，Piven L，et al.Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population ［J］.BMC microbiology，2020，20（1）：221.
|
| ［17］ |
Alqahtani SJ，Alfawaz HA，Moubayed NMS，et al.Bariatric surgery as treatment strategy of obesity in saudi people：effects of gut microbiota ［J］.Nutrients，2023，15（2）：361.
|
| ［18］ |
Yang J，Chen L，Shang XY，et al.Roux-en-Y gastric bypass-induced perturbative changes in microbial communities and metabolic pathways in rats ［J］.Front Microbiol，2022，13：1034839.
|
| ［19］ |
Prykhodko O，Burleigh S，Campanello M，et al.Long-term changes to the microbiome，blood lipid profiles and IL-6 in female and male swedish patients in response to bariatric Roux-en-Y gastric bypass ［J］.Nutrients，2024，16（4）：498.
|
| ［20］ |
Fouladi F，Carroll IM，Sharpton TJ，et al.A microbial signature following bariatric surgery is robustly consistent across multiple cohorts ［J］.Gut Microbes，2021，13（1）：1930872.
|
| ［21］ |
Gutiérrez-Repiso C，Garrido-Sánchez L，Alcaide-Torres J，et al.Predictive Role of Gut Microbiota in Weight Loss Achievement after Bariatric Surgery ［J］.Journal of the American College of Surgeons，2022，234（5）：861-871.
|
| ［22］ |
Visentin R，Brodersen K，Richelsen B，et al.increased insulin secretion and glucose effectiveness in obese patients with type 2 diabetes following bariatric surgery ［J］.Journal of diabetes research，2023，2023：7127426.
|
| ［23］ |
Hage K，Ikemiya K，Ghusn W，et al.Type 2 diabetes remission after Roux-en-Y gastric bypass：a multicentered experience with longterm follow-up ［J］.Surgery for Obesity and Related Diseases，2023，19（12）：1339-1345.
|
| ［24］ |
狄建忠，张弘玮，韩晓东，等.手术治疗2型糖尿病合并肥胖的初步临床经验 ［J］.上海医学，2013，36（03）：259-262.
|
| ［25］ |
Courcoulas AP，Patti ME，Hu B，et al.Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes ［J］.JAMA，2024，331（8）：654-664.
|
| ［26］ |
Blanchot A，Arbouche N，Ameline A，et al.Bariatric surgery and changes in metformin distribution：About a fatal case ［J］.Journal of pharmaceutical and biomedical analysis，2024，240：115956.
|
| ［27］ |
Hernández-Montoliu L，Rodríguez-Peña M M，Puig R，et al.A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass ［J］.Frontiers in endocrinology，2023，14：1181744.
|
| ［28］ |
Syn NL，Cummings DE，Wang LZ，et al.Association of metabolicbariatric surgery with long-term survival in adults with and without diabetes：a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants ［J］.Lancet （London，England），2021，397（10287）：1830-1841.
|
| ［29］ |
Svanevik M，Lorentzen J，Borgeraas H，et al.Patient-reported outcomes，weight loss，and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy （Oseberg）； a single-centre，randomised controlled trial ［J］.The lancet Diabetes & endocrinology，2023，11（8）：555-566.
|
| ［30］ |
Dang JT，Mocanu V，Park H，et al.Roux-en-Y gastric bypass and sleeve gastrectomy induce substantial and persistent changes in microbial communities and metabolic pathways ［J］.Gut Microbes，2022，14（1）：2050636.
|
| ［31］ |
Juárez-Fernández M，Román-Sagüillo S，Porras D，et al.Long-term effects of bariatric surgery on gut microbiota composition and faecal metabolome related to obesity remission ［J］.Nutrients，2021，13（8）：2519.
|
| ［32］ |
Anhê FF，Zlitni S，Zhang SY，et al.Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity ［J］.Gut，2023，72（3）：460-471.
|
| ［33］ |
Yadav J，Liang T，Qin T，et al.Gut microbiome modified by bariatric surgery improves insulin sensitivity and correlates with increased brown fat activity and energy expenditure ［J］.Cell reports Medicine，2023，4（5）：101051.
|
| ［34］ |
Monte SV，Caruana JA，Ghanim H，et al.Reduction in endotoxemia，oxidative and inflammatory stress，and insulin resistance after Rouxen-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus ［J］.Surgery，2012，151（4）：587-593.
|
| ［35］ |
Lee G，Park YS，Cho C，et al.Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass ［J］.Metabolomics，2021，17（8）：71.
|
| ［36］ |
Carmona-Maurici J，Cuello E，Ricart-Jané D，et al.Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity ［J］.Surgery for Obesity and Related Diseases，2020，16（12）：1961-1970.
|
| ［37］ |
Lunger L，Melmer A，Sturm W，et al.Bariatric surgery prevents carotid wall thickness progression ［J］.Wiener klinische Wochenschrift，2023，135（5-6）：151-157.
|
| ［38］ |
López-Montoya P，Cerqueda-García D，Rodríguez-Flores M，et al.association of gut microbiota with atherogenic dyslipidemia，and its impact on serum lipid levels after bariatric surgery ［J］.Nutrients，2022，14（17）：3545.
|
| ［39］ |
Carmona-Maurici J，Cuello E，Ricart-Jané D，et al.Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity ［J］.Surg Obes Relat Dis，2020，16（12）：1961-1970.
|
| ［40］ |
Axelrod CL，Langohr I，Dantas WS，et al.Weight-independent effects of Roux-en-Y gastric bypass surgery on remission of nonalcoholic fatty liver disease in mice ［J］.Obesity （Silver Spring，Md），2023，31（12）：2960-2971.
|
| ［41］ |
Lassailly G，Caiazzo R，Ntandja-Wandji LC，et al.Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis ［J］.Gastroenterology，2020，159（4）：1290-1301.e5.
|
| ［42］ |
Aminian A，Wilson R，Al-Kurd A，et al.Can nonalcoholic steatohepatitis be surgically cured？ Liver histologic comparison after metabolic surgery versus usual care ［J］.Ann Surg，2024，279（2）：276-282.
|
| ［43］ |
Verrastro O，Panunzi S，Castagneto-Gissey L，et al.Bariatricmetabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis （BRAVES）：a multicentre，open-label，randomised trial ［J］.Lancet （London，England），2023，401（10390）：1786-1797.
|
| ［44］ |
Dong TS，Katzka W，Yang JC，et al.Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease ［J］.Gut Microbes，2023，15（1）：2167170.
|
| ［45］ |
Ezquerro S，Mocha F，Frühbeck G，et al.Ghrelin reduces TNF-αinduced human hepatocyte apoptosis，autophagy，and pyroptosis：role in obesity-associated NAFLD ［J］.J Clin Endocrinol Metab，2019，104（1）：21-37.
|